What will be Wegovy's revenue from China by end of 2024? | Categorical | | | 6 months ago | |
Which company will hold the largest market share in China's weight-loss drug market by mid-2024? | Categorical | | | 6 months ago | |
Will Novo Nordisk's stock price increase by more than 10% by end of 2024? | Binary | | | 6 months ago | |
Will Blenrep re-enter the US market by December 31, 2025? | Binary | | | 14 days ago | |
How many patients will be using Wegovy in China by end of 2024? | Categorical | | | 6 months ago | |
Which Alzheimer's drug will lead the market share in China by end of 2025? | Categorical | | | 6 days ago | |
Which company will dominate the Alzheimer's treatment market in China by end of 2025? | Categorical | | | 6 days ago | |
How many new Alzheimer's treatments will be approved globally by end of 2025? | Categorical | | | 6 days ago | |
Will Eli Lilly's Alzheimer's drug be approved in another major market by end of 2025? | Binary | | | 6 days ago | |
Will Donanemab achieve significant market share in China by end of 2025? | Binary | | | 6 days ago | |
Will a major Alzheimer's treatment breakthrough be published by the US-Korea team by end of 2025? | Binary | | | 6 days ago | |
Outcome of Blenrep's priority review by China's NMPA by December 31, 2025 | Categorical | | | 14 days ago | |
Will China's NMPA approve Blenrep combination therapy by June 30, 2025? | Binary | | | 14 days ago | |
Will further positive results from the DREAMM-7 trial be published by December 31, 2025? | Binary | | | 14 days ago | |
GSK stock price change within a week of Blenrep's approval in China | Categorical | | | 14 days ago | |
Blenrep's global market share in multiple myeloma treatments by December 31, 2025 | Categorical | | | 14 days ago | |
Will Wegovy capture more than 10% market share in China by end of 2024? | Binary | | | 6 months ago | |
Will Wegovy receive approval in at least one additional major market by end of 2024? | Binary | | | 6 months ago | |